Cargando…
LECT2, A Novel and Direct Biomarker of Liver Fibrosis in Patients With CHB
Chronic hepatitis B (CHB) patients with severe liver fibrosis would be more likely to progress to a poorer prognosis. Treatment is considered once the liver fibrosis reaches significant liver fibrosis (≥S2). Leukocyte cell-derived chemotaxin-2 (LECT2) has been shown to contribute to liver fibrosis p...
Autores principales: | Xu, Honghai, Li, Xutong, Wu, Zihao, Zhao, Linyan, Shen, Jiapei, Liu, Jiaying, Qin, Jiangfeng, Shen, Yuanlong, Ke, Jing, Wei, Yuanyuan, Li, Jiabin, Gao, Yufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492992/ https://www.ncbi.nlm.nih.gov/pubmed/34631799 http://dx.doi.org/10.3389/fmolb.2021.749648 |
Ejemplares similares
-
Prognostic value of LECT2 and relevance to immune infiltration in hepatocellular carcinoma
por: Qin, Jiangfeng, et al.
Publicado: (2022) -
Dynamic Observation of Autophagy and Transcriptome Profiles in a Mouse Model of Bleomycin-Induced Pulmonary Fibrosis
por: Wang, Yani, et al.
Publicado: (2021) -
Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Ma, Jiaxiu, et al.
Publicado: (2022) -
Therapeutic Effects of the Bcl-2 Inhibitor on Bleomycin-induced Pulmonary Fibrosis in Mice
por: He, Yicheng, et al.
Publicado: (2021) -
Glucotoxicity Activation of IL6 and IL11 and Subsequent Induction of Fibrosis May Be Involved in the Pathogenesis of Islet Dysfunction
por: Lu, Liqin, et al.
Publicado: (2021)